Clinical efficacy of enfortumab vedotin-pembrolizumab (EV-P) in locally advanced (LA) or metastatic urothelial carcinoma (mUC): A real-world retrospective study. This is an ASCO Meeting Abstract from ...

Draft guidance from NICE recommends durvalumab before and after surgery for muscle-invasive bladder cancer following phase 3 trial survival data.

Overactive bladder, or OAB, is a medical condition characterized by increased urgency to urinate, increase frequency of urination, incontinence or poor bladder control and frequent nighttime urination ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...

A bladder spasm, also known as detrusor hyperreflexia, is when the bladder muscle squeezes involuntarily without warning. In addition to pain or discomfort, the spasms can lead to bladder leakage or ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...